NDC 42385-801 – emtricitabine, rilpivirine and tenofovir disoproxil fumarate
Emtricitabine 200 mg/1; Rilpivirine Hydrochloride 25 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral
Product NDC42385-801
Product details
- Brand name
- emtricitabine, rilpivirine and tenofovir disoproxil fumarate
- Generic name
- emtricitabine, rilpivirine and tenofovir disoproxil fumarate
- Labeler
- Laurus Labs Limited
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA220232
- Marketed since
- March 5, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Emtricitabine 200 mg/1
- Rilpivirine Hydrochloride 25 mg/1
- Tenofovir Disoproxil Fumarate 300 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 42385-801-30 | 30 TABLET, FILM COATED in 1 BOTTLE (42385-801-30) | Mar 5, 2026 |